5 ML daratumumab 20 MG/ML Injection
- RxCUI
- 1721951
- RxNorm name
- 5 ML daratumumab 20 MG/ML Injection
- Display name
- 5 ML daratumumab 20 MG/ML Injection
- Full name
- 5 ML daratumumab 20 MG/ML Injection
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:12
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761036 | Darzalex | daratumumab | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DARZALEX | DARATUMUMAB | Janssen Biotech, Inc. | a4d0efe9-5e54-467e-9eb4-56fa7d53b60b | 2026-06-05 | Warnings, Adverse reactions | 1721951 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a4d0efe9-5e54-467e-9eb4-56fa7d53b60b | 5 ML daratumumab 20 MG/ML Injection | SCD | 43 | These highlights do not include all the information needed to use DARZALEX safely and effectively. See full prescribing information for DARZALEX. DARZALEX ® (daratumumab) injection, for intravenous use Initial U.S. Approval: 2015 | 20251117 |
| a4d0efe9-5e54-467e-9eb4-56fa7d53b60b | daratumumab 100 MG per 5 ML Injection | SY | 43 | These highlights do not include all the information needed to use DARZALEX safely and effectively. See full prescribing information for DARZALEX. DARZALEX ® (daratumumab) injection, for intravenous use Initial U.S. Approval: 2015 | 20251117 |
| a4d0efe9-5e54-467e-9eb4-56fa7d53b60b | daratumumab 100 MG in 5 ML Injection | PSN | 43 | These highlights do not include all the information needed to use DARZALEX safely and effectively. See full prescribing information for DARZALEX. DARZALEX ® (daratumumab) injection, for intravenous use Initial U.S. Approval: 2015 | 20251117 |